Syndromic Testing Products
Syndromic Testing

QIAstat-Dx products

The next generation of syndromic insights

The size of a small printer, the QIAstat-Dx Analyzer can provide your lab with simultaneous qualitative detection and identification of multiple pathogens. With just one panel test, comprehensive results are around an hour away. The QIAstat-Dx Analyzer runs with all-in-one cartridges that contain preloaded reagents. Setting up a test takes less than one minute hands-on time and there's no need for precision pipetting. Powered by QIAstat-Dx, your lab can accelerate diagnosis and help improve patient care with rapid and accurate treatment.

Added insights: Ct values and amplification curves

Using real-time multiplex PCR, QIAstat-Dx offers additional insights with easy-to-view Ct values and amplification curves. Download the flyer to see for yourself.

QIAstat-Dx, QIAstat-Dx analyzer, syndromic testing, instrument, cartridge, sample prep, scan
Experience the easy workflow

See how quick and intuitive multiplex syndromic testing can be. Use this interactive demo to try out the QIAstat-Dx Analyzer for yourself.

Could your lab benefit from having a QIAstat-Dx?
Make the right choice for your lab.
QIAstat-Dx Analyzer features

The QIAstat-Dx Analyzer is a modular and scalable system designed to work in any clinical setting and make laboratory diagnostic testing faster and easier. The system runs assay cartridges, via displayed step-by step instructions, offering an intuitive user experience.

QIAstat-Dx Analyzer
Hands-on time Less than one minute
Test turnaround time 67–75 minutes (dependant on assay)
Throughput per day (24 hr) Up to 84 samples
Ct values and amplification curves Viewable for all detected pathogens
Interface Intuitive touchscreen
Connectivity Seamless integration with QIAsphere
LIS/LIMS Bidirectional capabilities
Batch testing with configurable queue Batch process 18 tests in a single run
Epidemiology reports Data and dashboard service through QIAsphere*
Continuous loading + urgent testing Each analytical module runs independently
Remote instrument status Available through QIAsphere*
Remote monitoring service Available through QIAsphere*
QIAstat-Dx Analyzer specifications
QIAstat-Dx Analyzer
Configuration Modular Syndromic Testing System
with one Operational Module and one Analytical Module
Weight Operational Module: 5 kg (11 lbs)
Analytical module: 16 kg (35 lbs)
Total Weight: 21 kg (46 lbs)
Dimensions (WxHxD) Operational Module: 234 x 326 x 517 mm (9.2 x 12.8 x 20.4 in)
Analytical module: 153 x 307 x 428 mm (6.0 x 12.0 x 16.8 in)
Total Dimension: 234 x 326 x 517 mm (9.2 x 12.8 x 20.4 in)
Power requirements 90–264 VAC
50–60 Hz IEC
60320-1 C14 socket
Recommended clearance 10 cm (4 in) on each side of the unit
QIAstat-Dx, QIAsphere, woman, lab, doctor
All the QIAstat-Dx capabilities at your fingertips

Using the QIAsphere app alongside your local network or cloud connection, you can remotely monitor your QIAstat-Dx Analyzer.

You’re free to walk away from your instruments while keeping track of test monitoring. And you can maximize use of your QIAstat-Dx Analyzer by reducing instrument downtime. 

Each QIAstat-Dx panel harnesses the power of our sleek cartridge design. This technology redefines ease-of use for multiplex testing by creating a workflow with less than one minute hands-on time.

  • Save time – all reagents are preloaded into the cartridge
  • Reduce errors and risk of contamination – tests are performed on a single instrument solution
  • Lower costs – cartridges are shipped and stored at room temperature

* Some features require a QIAstat-Dx Connectivity plan. Flexible plans are available to meet your lab’s needs.

The QIAstat-Dx Analyzer is intended for in vitro diagnostic use.

The QIAstat-Dx Respiratory SARS-CoV-2 Panel is intended for in vitro diagnostic use. 

  • This product has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories; 
  • This product has been authorized only for the detection and differentiation of nucleic acid of SARS-CoV-2 from multiple respiratory viral and bacterial organisms; and 
  • This emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetics Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declarations is terminated or authorization is revoked sooner.

For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit instructions for use or user manual. QIAGEN instructions for use and user manuals are available at or can be requested from QIAGEN Technical Services (or your local distributor).